AI assistant
ABBOTT LABORATORIES — Director's Dealing 2006
Feb 3, 2006
29777_dirs_2006-02-02_9a343edd-08e7-4887-9905-af4b25d61f81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-01-31
Reporting Person: LIEPMANN HOLGER A (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-01-31 | Common shares without par value | M | 2063 | $40.9283 | Acquired | 76948 | Direct |
| 2006-01-31 | Common shares without par value | S | 2063 | $42.73 | Disposed | 74885 | Direct |
| 2006-01-31 | Common shares without par value | M | 21281 | $33.2314 | Acquired | 96166 | Direct |
| 2006-01-31 | Common shares without par value | F | 17954 | $42.94 | Disposed | 78212 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-01-31 | Option (right to buy) | $40.9283 | M | 2063 | Disposed | 2006-02-08 | Common shares (2063) | Direct |
| 2006-01-31 | Option (right to buy) | $33.2314 | M | 21281 | Disposed | 2013-02-13 | Common shares (21281) | Direct |
| 2006-01-31 | Option (right to buy) | $42.94 | A | 17954 | Acquired | 2013-02-13 | Common shares (17954) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 13177 | Indirect |
| Common shares without par value | 295 | Indirect |
| Common shares without par value | 296 | Indirect |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2006.
F2: Reporting person disclaims beneficial ownership of shares held by his daughters.
F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3.
F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.